CD274 and non-small cell lung carcinoma: Assessment of PD-L1 expression can be challenging in NSCLC patients, due to sampling problems (both techniques require adequate tissue biopsies), dynamic changes in PD-L1 expression over time, and intra-tumor spatial heterogeneity, implying that analyzed tumor tissue may not be indicative of the whole tumor microenvironment (TME) [8].